Fundraising Fox
Nrxpharma
Wilmington, US · Founded 2017 · 1 known investors
Find your way into Nrxpharma
Sign up to see every warm intro you have to Nrxpharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Nrxpharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NRx Pharmaceuticals develops medicines for people with unmet medical needs, focused on making untreatable diseases treatable. It operates in the pharmaceutical and biotech industry.
Founders & leadership
Nrxpharma was founded in 2017 by Jonathan Javitt, Daniel C. Javitt, Jonathan C. Javitt, M.D., M.P.H., and Prof. Daniel C. Javitt, M.D., Ph.D..
JJ
Jonathan JavittFounder, Chairman & CEO
DC
Daniel C. JavittCo-founder & Chair, Scientific Advisory Board
JC
Jonathan C. Javitt, M.D., M.P.H.Founder, Chairman & Chief Scientist; Co-CEO HOPE TherapeuticsJavitt founded NeuroRx, Inc., which he led as CEO from 2015 to 2021, and previously co-founded Telcare, Inc., where he served as vice chairman, alongside a long tenure as a venture partner at Pontifax, LP. He is an adjunct professor of ophthalmology at Johns Hopkins Medicine and a senior fellow at the Potomac Institute for Policy Studies, and served as the company's chief scientist and a director before taking on his current role.
PD
Prof. Daniel C. Javitt, M.D., Ph.D.Co-founder & Chair, Scientific Advisory Board
MA
Michael AbramsChief Financial Officer
KB
Kim BennettChief Investment Officer
RA
Richard AckermanChairman, President and Chief Executive Officer
LB
Lori B. WittmanChief Financial Officer and Director
RP
Rick PanicucciChief Manufacturing Officer
DK
Dennis K. McBrideChief Strategy OfficerDennis McBride has over 45 years of experience applying scientific and engineering methods to complex technical analysis and decision support across litigation, government, medicine, and defense. A retired U.S. Navy Captain with advanced degrees in Human Factors Engineering and Modeling & Simulation, he previously held senior roles at DARPA, the Pentagon, and multiple defense research laboratories, and served as a professor in engineering and medicine.
JB
Joshua BrownChief Medical Innovation Officer
Investors · 1
Reported raises · per SEC filings
Form D private placements$6M disclosed across 2 rounds · 2017–2025
▶$3.5MraisedMar 2025 · 2 investors · BiotechnologyRule 506(b)
▶$3.5MraisedMar 2025 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Patrick FlynnDirector
- Michael AbramsExecutive Officer
- Michael TaylorDirector
- Jonathan JavittExecutive Officer, Director
- Chaim HurvitzDirector
- Dennis McBrideDirector
- Offering amount
- $3.5M
- Amount sold
- $3.5M
- Sales commissions
- $245K
- Placement agents
- D. Boral Capital
- First sale
- Jan 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedNov 2017 · 1 investors · CommercialRule 506(b)
▶$2.5MraisedNov 2017 · 1 investors · Commercial
Rule 506(b)Officers, directors & promoters on the filing
- Kim BennettExecutive Officer
- Michael FongDirector
- Richard AckermanExecutive Officer, Director
- Lori B. WittmanExecutive Officer, Director
- Troy T. TaylorDirector
- Stuart F. KoenigDirector
- Albert G. RexDirector
- Richard BardoffDirector
- Offering amount
- $2.8M
- Amount sold
- $2.5M
- Minimum investment
- $25K
- First sale
- Sep 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Seeking AlphaSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
RobinhoodRobinhood is a financial trading platform that enables users to manage portfolios across stocks, ETFs, cryptocurrencies, options, futures, and prediction markets. The platform serves retail investors with low barriers to entry, offering portfolio management services and market insights.
Companies working in the same space as Nrxpharma.
Frequently asked questions
- What does Nrxpharma do?
- NRx Pharmaceuticals develops medicines for people with unmet medical needs, focused on making untreatable diseases treatable. It operates in the pharmaceutical and biotech industry.
- Who founded Nrxpharma?
- Nrxpharma was founded by Jonathan Javitt, Daniel C. Javitt, Jonathan C. Javitt, M.D., M.P.H., Prof. Daniel C. Javitt, M.D., Ph.D. in 2017.
- Who are Nrxpharma's investors?
- Nrxpharma's investors include Kinled Holding.
- How much funding has Nrxpharma raised?
- Nrxpharma has disclosed $6M raised across 2 rounds.
- Where is Nrxpharma headquartered?
- Nrxpharma is headquartered in Wilmington, US.